Volv was founded to allow customers and partners to exploit latest developments in technology and data science to generate unique and powerful insights from data. Our mission is to speed science, reduce the cost of healthcare, and so enhance the economic output and well-being for all.
With inTrigue, Volv deliver accurate insight into rare diseases and targeted medicines enhanced by AI, delivering content to support earlier diagnosis through the discovery of new predictive digital biomarkers. We use high sensitivity proprietary methodologies to detect digital biomarkers across human diseases focussing in areas of significant unmet need or of difficult to diagnose conditions. We transform disease management and treatment for the first time at the level of the individual, especially where the cohorts cannot be easily determined. inTrigue reshapes medical practice, helping specialists make better clinical diagnoses for precision and personalised medicine, so that they can correctly treat the precise cohort of patients that will benefit.